Paige

United States
Troy, New Hampshire, United States, 10036

Company profile

Paige company profile

Paige was founded in 2017 by Thomas Fuchs, Dr.Sc., and colleagues from Memorial Sloan Kettering Cancer Center. The Company builds computational pathology products designed so patients and their care teams can make effective, more informed treatment decisions. With this new class of diagnostic devices positioned to drive the future of pathology, Paige created a platform to deliver this novel technology to pathologists to transform their workflow and increase diagnostic confidence and productivity. Paige’s lightweight platform was purpose-built with pathologists to offer an intuitive user experience, and minimize IT burden and costs while ensuring patient safety and data privacy. Paige’s products deliver insights to pathologists so they can arrive efficiently at more precise diagnoses for patients. Paige is the first company to receive FDA breakthrough designation for computational pathology products.

Business identity

Contact email
[email protected]
Operating status
Active
Company type
For Profit
Employee range
51-100 employees
Revenue range
$0-$1M
Founded
2018-02-01, Month

Headquarters

Postal code
10036
Country code
US
Continent
North America

Capital profile

Funding and company signals

Funding stage
M And A
Funding rounds
5
Total equity funding
$220M
Last funding
Series C / $125M / 2021-01-14
Last equity funding
Series C / $125M
Investors
8
Lead investors
6
Founders
5
Articles
59
Exited on
2025-08-22

Founders and investors

Founders

David KlimstraJoseph BoystakNorman SelbyPeter SchüfflerThomas Fuchs

Lead investors

Breyer CapitalCasdin CapitalGoldman Sachs Merchant Banking DivisionHealthcare Venture PartnersJohnson & Johnson InnovationKohlberg Kravis Roberts & Co.

Investors

Breyer CapitalCasdin CapitalCatalio Capital ManagementJohnson & Johnson InnovationKohlberg Kravis Roberts & Co.